Pulmonary Vein Blockage

Pulmonary veno-occlusive disease is a condition where small veins in the lungs become blocked, usually by scar tissue. This blockage can cause pressure buildup in the lungs and make it hard to breathe. It affects the veins in the lungs.

Condition

What people with Pulmonary Vein Blockage report

Every report comes from a Lived member, sent anonymously.

Have you had Lung transplant for Pulmonary Vein Blockage?

NameHow it went

About Pulmonary Vein Blockage

What It Is

Pulmonary veno-occlusive disease (PVOD) is a rare, serious condition in which abnormal scar-like tissue gradually narrows and blocks the small veins inside the lungs. These veins normally carry oxygen-rich blood from the lungs back to the heart. When they are blocked, blood backs up, pressure rises in the arteries that feed the lungs, and less oxygen reaches the rest of the body. That rise in pressure is called pulmonary hypertension, and it forces the right side of the heart to work much harder. The most common early symptoms are shortness of breath and tiredness during activity. Over time, people may notice dizziness, a lasting cough, trouble breathing when lying flat, swelling in the legs, chest pain or fainting. PVOD is a form of pulmonary arterial hypertension (PAH), but it tends to progress faster and responds differently to treatment, which is why telling it apart matters.

Causes & Risk Factors

The main known genetic cause is a change in a gene called EIF2AK4. In this inherited form, a person has a faulty copy of the gene from each parent. The parents usually have no symptoms themselves, and the disease often appears at a younger age than other cases. Most people with PVOD do not have this gene change. PVOD has been linked to certain chemotherapy medicines, especially mitomycin C and cyclophosphamide, to industrial solvents such as trichloroethylene, and to heavy tobacco smoking. It also occurs more often in people with systemic sclerosis (scleroderma) and has been reported after stem cell transplants. These are associations: they raise the likelihood but do not explain every case, and many people with PVOD have no identifiable exposure.

How It's Diagnosed

PVOD causes the same symptoms as other types of pulmonary arterial hypertension, and the two can look alike on many tests. Researchers estimate that 5 to 25 percent of people diagnosed with PAH of unknown cause actually have PVOD, so it is often recognized late or only after treatment goes poorly. The evaluation starts the way it does for any suspected pulmonary hypertension. An echocardiogram (heart ultrasound) estimates the pressure in the lungs and shows strain on the right side of the heart. Right heart catheterization, in which a thin tube is guided through a vein into the heart and lung arteries, measures those pressures directly and confirms pulmonary hypertension. Several clues then point toward PVOD rather than other PAH. A high-resolution chest CT scan may show hazy patches in the lungs, thickened lines between small lung segments and enlarged lymph nodes in the chest. Lung function testing often shows a marked drop in DLCO, a measure of how well oxygen passes from the air sacs into the blood, and oxygen levels are often low. A history of chemotherapy or solvent exposure adds weight, and genetic testing for EIF2AK4 can confirm the inherited form. A lung biopsy can show the blocked veins but is usually avoided because it carries a high risk of bleeding.

Treatment Options

There are no medicines proven to slow or reverse PVOD, and a lung transplant is the only treatment that can cure it. Because the disease can progress quickly, specialists recommend early referral to a pulmonary hypertension center, both for expert treatment and to begin a transplant evaluation promptly, sometimes as soon as PVOD is suspected. A recent or active cancer can rule out transplant, which matters for people whose PVOD followed chemotherapy. PVOD has rarely recurred in transplanted lungs. Supportive care helps with breathing and day-to-day symptoms. Oxygen therapy eases low oxygen levels. Diuretics (water pills) reduce fluid buildup when the right side of the heart is failing. Vaccines against flu, COVID-19 and pneumococcal pneumonia are important because infections can quickly worsen breathing. Supervised cardiopulmonary rehabilitation may help maintain strength. The medicines used for other forms of PAH, such as sildenafil (Revatio) or epoprostenol given by continuous infusion, relax and widen the lung arteries. In PVOD, the blockage lies beyond those arteries in the veins, so more blood flow can flood the lungs with fluid (pulmonary edema), which can be life-threatening. For this reason these medicines are used, if at all, cautiously, at low doses and under close specialist supervision, sometimes as a bridge to transplant. Medicines that calm the immune system have helped some people whose PVOD is linked to scleroderma or a stem cell transplant, but evidence comes only from small case series. For people who cannot have a transplant, palliative care specialists can help with breathlessness and planning care.

What to Expect

PVOD usually worsens over months to a few years, and it generally progresses faster than other forms of pulmonary arterial hypertension. In one registry of people with PVOD, about half were alive three years after diagnosis, and other reports describe shorter survival, though the course varies a great deal between people. Because PVOD is rare, these figures come from small groups and do not predict any one person's outcome. Daily life often involves using oxygen, pacing physical activity and planning around lower energy. Regular visits to the specialist center track symptoms, oxygen levels, walking distance and heart function, and help time decisions about transplant. Pulmonary hypertension makes pregnancy very dangerous for the mother, so specialists generally advise against it, and anyone who could become pregnant should ask their pulmonary hypertension team about reliable contraception soon after diagnosis. High altitude and air travel can lower oxygen levels further, so these are worth discussing in advance. For families of someone with the inherited form, genetic counseling can explain what testing relatives might mean.

When to Seek Help

See a doctor if shortness of breath or tiredness with activity keeps getting worse without a clear reason, especially after chemotherapy, solvent exposure or a diagnosis of scleroderma. If you have already been diagnosed with PAH and treatment is not helping, ask whether PVOD has been considered. Contact your pulmonary hypertension team right away if you become breathless with very little activity or at rest, need to sleep propped up to breathe, faint or nearly faint, notice new swelling in your legs or belly, or cough up any blood. This is especially important after starting or increasing a lung blood vessel medicine, since worsening breathlessness can be a sign of fluid in the lungs. Call 911 if breathing difficulty comes on suddenly or is so severe that you struggle to talk. Get emergency care if you cough up more than a few teaspoons of blood.

Questions to Ask Your Doctor

  1. 1.What makes you think this is PVOD rather than another type of pulmonary hypertension, and would genetic testing help?
  2. 2.Should I be referred to a pulmonary hypertension center and evaluated for a lung transplant now?
  3. 3.Are any lung blood vessel medicines safe to try in my case, and how will we watch for fluid in my lungs?
  4. 4.Which changes in my breathing, weight or swelling should prompt me to call you between visits?
  5. 5.What do my family members need to know if this could be inherited?

Last reviewed • Oct 2026

Educational content, not medical advice.